AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,436,491 | +252.1% | 58,040 | +302.7% | 0.00% | +200.0% |
| Q3 2022 | $408,000 | -57.8% | 14,413 | -66.9% | 0.00% | -50.0% |
| Q2 2022 | $966,000 | +101.7% | 43,563 | +198.8% | 0.00% | +100.0% |
| Q4 2021 | $479,000 | -74.8% | 14,581 | -66.8% | 0.00% | -90.0% |
| Q4 2020 | $1,901,000 | +37.2% | 43,878 | +10.8% | 0.01% | +11.1% |
| Q3 2020 | $1,386,000 | -29.2% | 39,593 | -28.3% | 0.01% | -55.0% |
| Q1 2020 | $1,959,000 | -76.5% | 55,234 | -68.4% | 0.02% | -64.9% |
| Q4 2019 | $8,344,000 | +261.4% | 174,735 | +145.2% | 0.06% | +216.7% |
| Q3 2019 | $2,309,000 | +1250.3% | 71,260 | +1817.1% | 0.02% | +800.0% |
| Q4 2018 | $171,000 | -63.0% | 3,717 | -32.3% | 0.00% | -71.4% |
| Q2 2018 | $462,000 | +103.5% | 5,490 | +97.9% | 0.01% | -22.2% |
| Q1 2018 | $227,000 | -64.6% | 2,774 | -71.1% | 0.01% | -70.0% |
| Q3 2017 | $642,000 | -49.6% | 9,587 | -68.6% | 0.03% | +275.0% |
| Q4 2016 | $1,274,000 | -77.6% | 30,528 | -71.6% | 0.01% | -80.0% |
| Q3 2016 | $5,675,000 | +1374.0% | 107,423 | +1033.9% | 0.04% | +900.0% |
| Q1 2016 | $385,000 | – | 9,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $80,873,000 | 75.24% |
| Casdin Capital, LLC | 187,500 | $7,855,000 | 7.82% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 40,000 | $1,676,000 | 4.87% |
| BB BIOTECH AG | 2,363,321 | $99,011,000 | 3.91% |
| AlpInvest Partners B.V. | 30,000 | $1,257,000 | 2.49% |
| Opaleye Management Inc. | 85,000 | $3,561,000 | 2.38% |
| Opus Point Partners Management, LLC | 43,295 | $1,814,000 | 1.75% |
| Clarius Group, LLC | 47,666 | $1,997,000 | 1.06% |
| CAPITAL INTERNATIONAL LTD /CA/ | 260,600 | $10,918,000 | 0.79% |
| Eventide Asset Management | 300,800 | $12,602,000 | 0.77% |